Weekly reads: 1st FDA-approved CIRM supported therapy, asymmetric histone inheritance, stem cell retraction
Professor Paul Knoepfler, Ph.D.
We recently saw exciting news with the first CIRM-funded therapy garnering FDA approval.
Before we jump into that and other news and new publications, a reminder that my lab is still crowdfunding to support our brain tumor research in these tough funding times. Please consider making a tax-deductible gift to give more hope for kids and adults facing brain tumors. Thanks!
CIRM-funded therapy gets FDA approval
The approved therapy supported by CIRM funding is KRESLADI from Rocket Pharmaceuticals,.